Humoral efficacy of the third SARS-CoV-2 vaccine dose in Multiple Sclerosis subjects undergoing different disease-modifying therapies

BACKGROUND: It remains unclear how vaccine doses and combinations of vaccination and infection affect the magnitude and quality of immune responses, particularly against novel SARS-CoV-2 variants in subjects with immune-related disorders, such as people with multiple sclerosis (pwMS). Several studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Maniscalco, Giorgia Teresa, Liotti, Antonietta, Ferrara, Anne Lise, Prestipino, Elio, Salvatore, Simona, Di Battista, Maria Elena, Moreggia, Ornella, Di Giulio Cesare, Daniele, Vastano, Roberta, Belardo, Martina, Napolitano, Massimo, Ranieri, Angelo, Longo, Katia, Andreone, Vincenzo, De Rosa, Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595409/
https://www.ncbi.nlm.nih.gov/pubmed/36544318
http://dx.doi.org/10.1016/j.msard.2022.104371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595409/
https://www.ncbi.nlm.nih.gov/pubmed/36544318
http://dx.doi.org/10.1016/j.msard.2022.104371

Ejemplares similares